Literature DB >> 2578532

Exploitation of phylogenetic distance in cell surface immune labeling: studies with beta 2-microglobulin.

J J Horton, C A Holden, P J Ward, D M MacDonald, A R Sanderson.   

Abstract

Beta 2-microglobulin (beta 2M) is part of the HLA molecule, and is found on the cell surface of human nucleated cells. In certain skin tumors, malignant change has been associated with a loss of this surface beta 2M, indicating a possible diagnostic value for this marker. At present beta 2M is best identified in paraffin-embedded tissue by means of a triple-layer peroxidase-antiperoxidase technique, using mammalian polyclonal antisera. Recently a polyclonal antiserum against human beta 2M has been produced in chickens. Because of the phylogenetic differences between the species, the resulting antiserum is likely to recognize more epitopes on the beta 2M and show greater sensitivity than antisera raised in mammalian species. To confirm this hypothesis, the avian antiserum was compared to both mammalian polyclonal (rabbit) and monoclonal (mouse) antibody in vitro. beta 2M fixed to plastic surfaces combined with more avian than mammalian antibody. Furthermore, insolubilized chicken antibody could bind more secondary antibody-horseradish peroxidase conjugate than could insolubilized mammalian antibody, thus showing even greater enhancement with this system. Immunohistochemical analysis of these systems confirmed that the chicken strategy has greater sensitivity, and can be used in an indirect system with consequent reduction in nonspecific background activity. It is the most suitable technique for the investigation of the distribution of beta 2M in paraffin-embedded tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578532     DOI: 10.1111/1523-1747.ep12274979

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.

Authors:  R A Jones; S J Richards; D Patel; C S Scott
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

2.  Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms.

Authors:  Yasmina Noubia Abdiche; Rian Harriman; Xiaodi Deng; Yik Andy Yeung; Adam Miles; Winse Morishige; Leila Boustany; Lei Zhu; Shelley Mettler Izquierdo; William Harriman
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

3.  High-efficiency antibody discovery achieved with multiplexed microscopy.

Authors:  Shelley Mettler Izquierdo; Stephanie Varela; Minha Park; Ellen J Collarini; Daniel Lu; Shreya Pramanick; Joseph Rucker; Lucia Lopalco; Rob Etches; William Harriman
Journal:  Microscopy (Oxf)       Date:  2016-04-21       Impact factor: 1.571

Review 4.  IgY: a promising antibody for use in immunodiagnostic and in immunotherapy.

Authors:  Wilmar Dias da Silva; Denise V Tambourgi
Journal:  Vet Immunol Immunopathol       Date:  2010-01-07       Impact factor: 2.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.